We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Surgical Recovery Correlates with Single-Cell Immune Signatures

By LabMedica International staff writers
Posted on 15 Oct 2014
The activity level of a small set of immune cells during the first 24 hours after surgery provides strong clues to how quickly patients will recover from surgery-induced fatigue and pain. More...


A highly sensitive technology, called single-cell mass cytometry, enables simultaneous monitoring of large numbers of biochemical features both on the surfaces of immune cells and within the cells, providing information of what kind of cells are present and whether they are active.

Scientists at Stanford University Medical Center (CA, USA) recruited 32 otherwise healthy patients, mostly between ages 50 and 80, who were undergoing first-time hip-replacement procedures. Blood samples from these patients were drawn 1 hour before surgery, then at 1, 24 and 72 hours postsurgery and again four to six weeks after surgery. Cytometric analysis of 35 features in and on each sample's roughly half-million constituent cells yielded profiles of the cells' identities along with key activities underway inside them. Stained cells were analyzed on a CyTOF mass cytometer (DVS Sciences; Sunnyvale, CA, USA) at an event rate of 400 to 500 cells per second.

The simultaneous analysis of 14,000 phosphorylation events in precisely phenotyped immune cell subsets revealed uniform signaling responses among patients, demarcating a surgical immune signature. When regressed against clinical parameters of surgical recovery, including functional impairment and pain, strong correlations were found with signal transducer and activator of transcription (STAT3), adenosine 3′,5′-monophosphate response element–binding protein (CREB) , and nuclear factor κB (NF-κB) signaling responses in subsets of cluster of differentiation 14+ (CD14+) monocytes. The cells in question account for only about 1% to 2% of all the white blood cells found in a typical sample of a healthy person's blood, so the changes within them could easily have been missed had a less-thorough detection technology been employed.

Brice Gaudilliere, MD, PhD, a lead author of the study, said, “If we could predict recovery time before surgery even took place we might be able to see who'd benefit from boosting their immune strength beforehand, or from presurgery interventions such as physical therapy. It might even help us decide when or if a patient should have surgery.” The study was published on September 24, 2014, in the journal Science Translational Medicine.

Related Links:

Stanford University Medical Center
DVS Sciences



New
Gold Member
Collection and Transport System
PurSafe Plus®
Portable Electronic Pipette
Mini 96
6 Part Hematology Analyzer with RET + IPF
Mispa HX 88
ESR Analyzer
TEST1 2.0
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: New evidence shows viscoelastic testing can improve assessment of blood clotting during postpartum hemorrhage (Photo courtesy of 123RF)

Viscoelastic Testing Could Improve Treatment of Maternal Hemorrhage

Postpartum hemorrhage, severe bleeding after childbirth, remains one of the leading causes of maternal mortality worldwide, yet many of these deaths are preventable. Standard care can be hindered by delays... Read more

Industry

view channel
Image: The collaboration aims to improve access to Hb variant testing with the Gazelle POC diagnostic platform (Photo courtesy of Hemex Health)

Terumo BCT and Hemex Health Collaborate to Improve Access to Testing for Hemoglobin Disorders

Millions of people worldwide living with sickle cell disease and other hemoglobin disorders experience delayed diagnosis and limited access to effective care, particularly in regions where testing is scarce.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.